Ganguly S, Margel S
Micromachines (Basel). 2025; 16(2).
PMID: 40047623
PMC: 11857720.
DOI: 10.3390/mi16020174.
Almehdi A, Aboubaker D, Hamdy R, El-Keblawy A
Toxicol Rep. 2025; 14:101906.
PMID: 39926413
PMC: 11803169.
DOI: 10.1016/j.toxrep.2025.101906.
Ranasinghe R, Mathai M, Alshawsh M, Zulli A
Heliyon. 2025; 10(7):e28171.
PMID: 39839154
PMC: 11747978.
DOI: 10.1016/j.heliyon.2024.e28171.
Hong S, Kim S, Chung C, Yun C, Lee J, Cho C
Microbiol Spectr. 2024; :e0104824.
PMID: 39540747
PMC: 11619324.
DOI: 10.1128/spectrum.01048-24.
Jain B, Verma D, Rawat R, Berdimurodov E
Curr Pharm Des. 2024; 30(38):3018-3037.
PMID: 39143881
DOI: 10.2174/0113816128317407240724065912.
Advances in active targeting of ligand-directed polymeric nanomicelles exploiting overexpressed cellular receptors for precise nanomedicine.
Agwa M, Marzouk R, Sabra S
RSC Adv. 2024; 14(32):23520-23542.
PMID: 39071479
PMC: 11273262.
DOI: 10.1039/d4ra04069d.
Nanoplastics and Neurodegeneration in ALS.
Eisen A, Pioro E, Goutman S, Kiernan M
Brain Sci. 2024; 14(5).
PMID: 38790450
PMC: 11119293.
DOI: 10.3390/brainsci14050471.
How Shilajit-Based Nanocarriers Alter Classical Doxorubicin Delivery to Breast Cancer Cells (MCF-7 and ZR-75-1).
Asadi Z, Jalilian S, Arkan E, Aghaz F
ACS Med Chem Lett. 2024; 15(4):449-456.
PMID: 38628801
PMC: 11017394.
DOI: 10.1021/acsmedchemlett.3c00538.
The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.
Huang Q, Ge Y, He Y, Wu J, Tong Y, Shang H
Int J Nanomedicine. 2024; 19:3333-3365.
PMID: 38617796
PMC: 11012801.
DOI: 10.2147/IJN.S447350.
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents.
Preeti , Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Saharan R
Int J Hypertens. 2024; 2024:2430147.
PMID: 38410720
PMC: 10896658.
DOI: 10.1155/2024/2430147.
Effective Strategies in Designing Chitosan-hyaluronic Acid Nanocarriers: From Synthesis to Drug Delivery Towards Chemotherapy.
Hong L, Ho T, Cu S, Ngan L, Quyen Tran N, Dang T
Curr Drug Deliv. 2024; 22(1):41-62.
PMID: 38310441
DOI: 10.2174/0115672018275983231207101222.
Therapeutic Peptides Are Preferentially Solubilized in Specific Microenvironments within PEG-PLGA Polymer Nanoparticles.
Lopez-Rios de Castro R, Ziolek R, Ulmschneider M, Lorenz C
Nano Lett. 2024; 24(6):2011-2017.
PMID: 38306708
PMC: 10870757.
DOI: 10.1021/acs.nanolett.3c04558.
Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective.
Zhang Y, Wu Y, Du H, Li Z, Bai X, Wu Y
Pharmaceutics. 2024; 16(1).
PMID: 38276483
PMC: 10820767.
DOI: 10.3390/pharmaceutics16010007.
Nanoparticle-Facilitated Therapy: Advancing Tools in Peripheral Nerve Regeneration.
Shi S, Ou X, Cheng D
Int J Nanomedicine. 2024; 19:19-34.
PMID: 38187908
PMC: 10771795.
DOI: 10.2147/IJN.S442775.
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches.
Aryal S, Park S, Park H, Park C, Kim W, Thakur D
Int J Nanomedicine. 2023; 18:7865-7888.
PMID: 38146467
PMC: 10749572.
DOI: 10.2147/IJN.S432839.
Anionic Hyperbranched Amphiphilic Polyelectrolytes as Nanocarriers for Antimicrobial Proteins and Peptides.
Balafouti A, Forys A, Trzebicka B, Gerardos A, Pispas S
Materials (Basel). 2023; 16(24).
PMID: 38138846
PMC: 10745097.
DOI: 10.3390/ma16247702.
Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery.
Hajareh Haghighi F, Binaymotlagh R, Fratoddi I, Chronopoulou L, Palocci C
Gels. 2023; 9(12).
PMID: 38131939
PMC: 10742474.
DOI: 10.3390/gels9120953.
Application of Nanoparticles in Cancer Treatment: A Concise Review.
Sell M, Lopes A, Escudeiro M, Esteves B, Monteiro A, Trindade T
Nanomaterials (Basel). 2023; 13(21).
PMID: 37947732
PMC: 10650201.
DOI: 10.3390/nano13212887.
Alginate-based hydrogel platform embedding silver nanoparticles and cisplatin: characterization of the synergistic effect on a breast cancer cell line.
Maher S, Kalil H, Liu G, Sossey-Alaoui K, Bayachou M
Front Mol Biosci. 2023; 10:1242838.
PMID: 37936720
PMC: 10626534.
DOI: 10.3389/fmolb.2023.1242838.
Natural medicine delivery from 3D printed bone substitutes.
Bose S, Sarkar N, Jo Y
J Control Release. 2023; 365:848-875.
PMID: 37734674
PMC: 11147672.
DOI: 10.1016/j.jconrel.2023.09.025.